Glycolipid depletion in antimicrobial therapy.

Glycolipid depletion in antimicrobial therapy.

Mucosal pathogens target sites of infection through specific adherence to host glycoconjugate receptors. As a consequence, depletion of such receptors from the cell surface may be expected to inhibit attachment, impair bacterial colonization and reduce the activation of mucosal inflammation. We have...

Descrizione completa

Dettagli Bibliografici
Autori principali:	Svensson, M, Frendeus, B, Butters, T, Platt, F, Dwek, R, Svanborg, C
Natura:	Journal article
Lingua:	English
Pubblicazione:	2003

Documenti analoghi

Glycolipid receptor depletion as an approach to specific antimicrobial therapy.
di: Svensson, M, et al.
Pubblicazione: (2006)

Carbohydrate receptor depletion as an antimicrobial strategy for prevention of urinary tract infection.
di: Svensson, M, et al.
Pubblicazione: (2001)

Glycolipids in cell biology and medicine - Introduction
di: Dwek, R, et al.
Pubblicazione: (2003)

Small-molecule therapeutics for the treatment of glycolipid lysosomal storage disorders.
di: Butters, T, et al.
Pubblicazione: (2003)

Inhibition of substrate synthesis as a strategy for glycolipid lysosomal storage disease therapy.
di: Platt, F, et al.
Pubblicazione: (2001)

Glycosphingolipid lysosomal storage diseases: therapy and pathogenesis.
di: Jeyakumar, M, et al.
Pubblicazione: (2002)

Imino sugar therapy for type 1 Gaucher disease.
di: Priestman, D, et al.
Pubblicazione: (2000)

Contributions of Glycolipid Biosurfactants and Glycolipid-Modified Materials to Antimicrobial Strategy: A Review
di: Qin Shu, et al.
Pubblicazione: (2021-02-01)

CD1d presentation of glycolipids.
di: Speak, A, et al.
Pubblicazione: (2008)

Pharmacotherapeutic strategies using small molecules for the treatment of glycolipid lysosomal storage disorders.
di: Butters, T
Pubblicazione: (2007)

Therapeutic applications of imino sugars in lysosomal storage disorders.
di: Butters, T, et al.
Pubblicazione: (2003)

New therapeutics for the treatment of glycosphingolipid lysosomal storage diseases.
di: Butters, T, et al.
Pubblicazione: (2003)

Imino sugar inhibitors for treating the lysosomal glycosphingolipidoses.
di: Butters, T, et al.
Pubblicazione: (2005)

Inhibition of glycosphingolipid biosynthesis: application to lysosomal storage disorders.
di: Butters, T, et al.
Pubblicazione: (2000)

Iminosugar inhibitors for treating the lysosomal glycosphingolipidoses
di: Butters, T, et al.
Pubblicazione: (2005)

Substrate reduction therapy in mouse models of the glycosphingolipidoses.
di: Platt, F, et al.
Pubblicazione: (2003)

Introduction
di: Dwek, R, et al.
Pubblicazione: (2003)

Storage solutions: treating lysosomal disorders of the brain.
di: Jeyakumar, M, et al.
Pubblicazione: (2005)

Glycolipids/
di: Wiegandt, H.
Pubblicazione: (1985)

Membrane disruption and cytotoxicity of hydrophobic N-alkylated imino sugars is independent of the inhibition of protein and lipid glycosylation.
di: Mellor, H, et al.
Pubblicazione: (2003)

Targeting glycosylation as a therapeutic approach.
di: Dwek, R, et al.
Pubblicazione: (2002)

N-butyldeoxygalactonojirimycin: a more selective inhibitor of glycosphingolipid biosynthesis than N-butyldeoxynojirimycin, in vitro and in vivo.
di: Andersson, U, et al.
Pubblicazione: (2000)

Control of Alicyclobacillus acidoterrestris in Apple Juice with Natural Antimicrobial Glycolipid
di: Rory Wang, et al.
Pubblicazione: (2025-02-01)

Substrate reduction therapy
di: Platt, F, et al.
Pubblicazione: (2007)

Modulation of THP-1 macrophage and cholesterol-loaded foam cell apolipoprotein E levels by glycosphingolipids.
di: Garner, B, et al.
Pubblicazione: (2002)

Improved outcome of N-butyldeoxygalactonojirimycin-mediated substrate reduction therapy in a mouse model of Sandhoff disease.
di: Andersson, U, et al.
Pubblicazione: (2004)

The liganding of glycolipid transfer protein is controlled by glycolipid acyl structure.
di: Lucy Malinina, et al.
Pubblicazione: (2006-11-01)

Tuning the antimicrobial activity of microbial glycolipid biosurfactants through chemical modification
di: Melike Pala, et al.
Pubblicazione: (2024-02-01)

New developments in treating glycosphingolipid storage diseases.
di: Platt, F, et al.
Pubblicazione: (2005)

Glycosylation: disease targets and therapy.
di: Zitzmann, N, et al.
Pubblicazione: (2005)

High-performance cation-exchange chromatography and pulsed amperometric detection for the separation, detection, and quantitation of N-alkylated imino sugars in biological samples.
di: Mellor, H, et al.
Pubblicazione: (2000)

Inhibition of glycogen breakdown by imino sugars in vitro and in vivo.
di: Andersson, U, et al.
Pubblicazione: (2004)

Soluble human TLR2 ectodomain binds diacylglycerol from microbial lipopeptides and glycolipids.
di: Jiménez-Dalmaroni, M, et al.
Pubblicazione: (2015)

Glycolipids : new research /
di: Sasaki, Daiki
Pubblicazione: (c200)

Inhibition of glucosylceramide synthase does not reverse drug resistance in cancer cells.
di: Norris-Cervetto, E, et al.
Pubblicazione: (2004)

Enhanced survival in Sandhoff disease mice receiving a combination of substrate deprivation therapy and bone marrow transplantation.
di: Jeyakumar, M, et al.
Pubblicazione: (2001)

Long-term non-hormonal male contraception in mice using N-butyldeoxynojirimycin.
di: Walden, C, et al.
Pubblicazione: (2006)

Synergistic Treatment of Breast Cancer by Combining the Antimicrobial Peptide Piscidin with a Modified Glycolipid
di: Rebecca T. Miceli, et al.
Pubblicazione: (2024-07-01)

Pyroelectric detection in glycolipid thin film
di: Kwong, W.L., et al.
Pubblicazione: (2010)

Pharmacological impairment of acrosome formation and sperm head morphogenesis reveals essential role of glycosphingolipids in spermiogenesis
di: van der Spoel, A, et al.
Pubblicazione: (2002)